Ascentage Pharma strengthens its US commercialization team by appointing a new Chief Business Officer and Chief Commercial Officer
Executive summary: Ascentage Pharma appointed Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer on August 2, 2026. The appointments signal a heightened focus on US commercialization and could accelerate the company's market entry efforts.
Who is involved: Ascentage Pharma, Dr. Faiçal Miyara, Jim Ziegler.
Likely next: The new executives will likely shape US market strategy, potentially leading to partnership discussions or preparatory activities for product launches.
Ascentage Pharma announced the appointment of Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer on August 2, 2026. The moves are intended to underscore the company's commitment to expanding its presence in the United States market. By adding experienced executives to lead business and commercial functions, Ascentage aims to accelerate the development and launch of its pipeline products in the US.
Timeline
- — Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer (GlobeNewswire)
Analysis — what this means
Sectors affected
- oncology therapeutics